In an era dominated by rapid advancements in artificial intelligence (AI), the need for robust governance frameworks has never been more critical. The Universal Guidelines on Artificial Intelligence (UGAI) represented a pioneering effort to address the ethical, legal, and societal challenges posed by AI technologies.

Clinical documentation is a critical component in the healthcare and pharmaceutical industries, serving as the backbone for clinical studies, regulatory submissions, and patient care. Developing and maintaining metrics for the production of clinical documentation is essential to ensure quality, compliance, and efficiency and to be able to identify and mitigate risk during this process.

In today’s rapid digital transformation of the clinical trials space, artificial intelligence (AI) is becoming an indispensable part of meeting business goals and improving patient care and treatment.

In the realm of medical writing, titles like "regulatory" or "pharma" may take center stage, overshadowing the less emphasized term "ethical medical writer."

The environmental impact of artificial intelligence (AI) is increasingly scrutinized due to the significant energy consumption and carbon emissions associated with data centers and computational processes. As a product of Synterex, AgileWriter.ai embodies a unique position in the AI landscape, integrating Synterex’s rigorous sustainability practices to mitigate environmental impacts effectively.

Artificial intelligence (AI) continues to reshape industries, societies, and economies globally. As AI technologies evolve and integrate deeper into various sectors, establishing robust frameworks to manage their development and use becomes crucial. The Organization for Economic Co-operation and Development (OECD) has taken significant steps in this direction with its Recommendation on Artificial Intelligence.